Publication | Closed Access
Safety and Pharmacokinetics of Ribavirin for the Treatment of La Crosse Encephalitis
38
Citations
27
References
2011
Year
Although the results do not support the use of RBV for LACVE, this nevertheless is the largest study of antiviral treatment for LACVE to date and the largest pharmacokinetic analysis of IV RBV in children for any indication.
| Year | Citations | |
|---|---|---|
Page 1
Page 1